Severe infections in patients with chronic lymphocytic leukemia included in trials investigating BTK and BCL2 inhibitors.
Saved in:
| Title: | Severe infections in patients with chronic lymphocytic leukemia included in trials investigating BTK and BCL2 inhibitors. |
|---|---|
| Authors: | Mauro FR; Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy. Electronic address: mauro@bce.uniroma1.it., Frustaci AM; ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy., Visentin A; Hematology and Clinical Immunology Unit, Department of Medicine, University of Padua, Italy., Vitale C; Division of Hematology, A.O.U. Città della Salute e della Scienza di Torino, Italy; Department of Molecular Biotechnology and Health Sciences, University of Turin, Italy., Bartoletti M; Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, Pieve Emanuele Milan 20090, Italy; Infectious Disease Unit, IRCCS Humanitas Research Hospital, Via Manzoni 56, Rozzano, Milan 20089, Italy., Oltolini C; Clinic of Infectious Diseases, Vita-Salute University, San Raffaele Scientific Institute, Milan, Italy., Zappulo E; Department of Clinical Medicine and Surgery University of Naples Federico II, Napoli, Italy., Mikulska M; Department of Health Sciences (DISSAL) University of Genoa, Italy; Infectious Diseases Unit IRCCS Ospedale Policlinico San Martino Genoa, Italy. |
| Source: | Critical reviews in oncology/hematology [Crit Rev Oncol Hematol] 2024 Sep; Vol. 201, pp. 104408. Date of Electronic Publication: 2024 Jun 14. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Elsevier Scientific Publishers Country of Publication: Netherlands NLM ID: 8916049 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0461 (Electronic) Linking ISSN: 10408428 NLM ISO Abbreviation: Crit Rev Oncol Hematol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
